Bracebridge H Jr Young

Director Young buys 10,000 FLD shares at $1.03; stock now $1.00, down 82.0% from 52-week high, company unprofitable

Director Bracebridge H Jr Young purchased 10,000 shares at $1.03 on 2026-05-27, increasing his holdings from 40,100 to 50,100 shares. The purchase occurred as Fold Holdings trades near a 52-week low: the current price of $1.00 is -82.0% from the 52-week high of $5.54 and -33.3% over the prior 30 days. Young's own prior four buys at FLD have posted negative 90-day returns in three instances (-18.6%, -52.3%, -22.2%), with only one modestly positive (3.8%), suggesting a poor track record of timing at this ticker. Critically, the company remains unprofitable with a net income of $-29.2M on quarterly revenue of $5.6M, despite 33.8% annual revenue growth. This combination—a distressed valuation, repeated unfavorable prior buys by the same insider, and ongoing losses—presents material uncertainty about the investment thesis supporting the director's continued accumulation.

Director Young Bracebridge H Jr bought 8,500 shares of FLD at $1.24; stock down 78.3% from 52-week high, director's prior buys show 0% 90-day win rate.

Director Young Bracebridge H Jr purchased 8,500 shares at $1.24 on 2026-05-18, increasing his holdings by 26.9% to 40,100 shares total. The purchase occurs while FLD trades at $1.20, down 78.3% from its 52-week high of $5.54 and down 23.1% over the prior 30 days. Across his cross-ticker history, the insider's 3 prior open-market buys averaged -8.1% 30-day returns and -28.0% 90-day returns with a 0.00% 90-day win rate. At this specific ticker, his prior 3 buys (on 2025-12-01, 2025-08-26, and 2025-08-19) showed returns of -52.3%, -9.5%, and -22.2% at the 90-day mark, with 0 of 3 prior buys well-timed. The company generated $5.6M in quarterly revenue but posted a net loss of $29.2M, remaining unprofitable over its most recent full fiscal year despite 33.8% annual revenue growth.

Director Young Bracebridge H Jr purchases 8,100 shares of FLD at $3.12; stock down 73.6% from 52-week high, insider's prior buys underperformed.

Director Young Bracebridge H Jr purchased 8,100 shares of Fold Holdings at $3.12, increasing holdings by 34.5% to 31,600 shares total. The purchase occurs against a deteriorating price backdrop: FLD trades at $3.00, down 73.6% from its 52-week high of $11.35, and has declined 14.3% over the prior 30 days. Critically, the insider's track record on prior buys across all tickers shows an average 90-day return of -15.8% with a 0.00% win rate, and at this specific ticker, 0 of 2 prior buy transactions were well-timed at the 90-day mark, with one prior buy (2025-08-19) posting a 90-day return of -22.2%. The company is unprofitable on a full-year basis despite generating $7.4M in quarterly revenue, adding fundamental uncertainty to the investment thesis.

Director Bracebridge bought 8,500 FLD shares at $3.45; second buy in 7 days as stock down -68.0% from 52-week high

Young Bracebridge H Jr acquired 8,500 shares at $3.45 on 2025-08-26, boosting his holdings to 23,500 shares (+56.7% increase). This represents his second open-market purchase within seven days—he also bought on 2025-08-19. The timing occurs with the stock trading at $3.64 (current price), down -68.0% from its 52-week high of $11.38 and -14.6% over the past 30 days. FLD reported latest-quarter revenue of $8,175,926.00 and net income of $13,425,567.00; however, the company was unprofitable over its most recent full fiscal year, creating a disconnect between quarterly positive earnings and annual negative results. The rapid sequential buying at depressed price levels, combined with the company's full-year unprofitability despite recent quarterly strength, presents a mixed signal that warrants scrutiny of cash flow sustainability and financial trajectory.

Director Bracebridge bought 7,700 shares of FLD at $3.85; +105.5% to holdings amid stock down -66.9% from 52-week high

Young Bracebridge H Jr, a director, purchased 7,700 shares at $3.85 on 2025-08-19, increasing his holdings from 7,300 to 15,000 shares—a 105.5% increase in position size. The timing follows a pronounced decline: the stock has fallen -66.9% from its 52-week high of $11.38 and dropped -14.5% over the prior 30 days. However, the broader financial context contains a significant contradiction: the company reported positive net income of $13,425,567.00 in the latest quarter yet was unprofitable over the full fiscal year. This mix of a director accumulating shares at depressed price levels during both annual and recent-term declines, combined with the unresolved question of full-year profitability versus recent quarterly strength, merits examination of the company's underlying trajectory.